Abstract: A 3D printing method for an impact-resistant gradient complex part containing a hollow ceramic sphere complex, wherein the method includes the following steps: 1) designing the size and shape of the part as well as an internal layered structure; 2) providing a raw material, wherein the raw material contains a high polymer, a curing agent and hollow ceramic spheres; and 3) providing the raw material with a certain thickness according to a design, then, curing the raw material by using a heat source to form a high polymer layer containing the hollow ceramic spheres, and repeatedly printing the high polymer layer according to the design until the high polymer layer reaches the designed thickness to form the impact-resistant gradient complex part.

Abstract: A composite containing hollow ceramic spheres and a preparation method are provided. The composite includes an impact-resistant gradient complex part containing a hollow ceramic sphere complex, prepared by using a 3D printing method and a hollow ceramic sphere-high polymer complex dielectric material obtained in a blending and fusing way. The obtained composite has the characteristics of relatively low density and high strength. The impact-resistant gradient complex part is a layered complex, the composition and properties of the complex may be regulated in a direction vertical to a layer according to a design, for example, mechanical properties of the complex are transitioned from soft to hard to form gradient change by regulating the change of the composition, and meanwhile, the thickness among layers with different properties is accurately controlled as required.

Abstract: Described herein is a composition for submucosal injection comprises a biocompatible modified starch and a pharmaceutically acceptable carrier for injection. The biocompatible modified starch is in an amount ranging from 0.2 wt % to 50 wt % of the total weight of composition. The biocompatible modified starch is selected from one or more of the group consisting of: etherified starches, esterified starches, cross-linked starches, pre-gelatinized starches, graft starches and composite modified starches, which has a molecular weight ranging from 3,000 to 2,000,000 daltons, a water absorbency capability of at least twice of its own weight, and a particle size from 500 nm to 1000 ?m. The viscosity of the composition ranges from 9 mPa·s to 150,000 mPa·s at 25° C. The present disclosure also provides a combination reagent for submucosal injection, comprising the above-mentioned biocompatible modified starch and the pharmaceutically acceptable carrier for injection.

Abstract: Disclosed herein is a biocompatible ultrasonic coupling agent for endoscopes, comprising a biocompatible modified starch and a pharmaceutically acceptable carrier, or comprising an ingredient selected from the group consisting of cellulose, polyvinylpyrrolidone, polyoxyethylene, sodium alginate, glucan, hyaluronic acid, chitosan, light sensitive glue, ultrasonic sensitive glue, pH sensitive glue, gelatin and carbomer, and a pharmaceutically acceptable carrier; wherein the ultrasonic coupling agent produces an acoustic characteristic impedance matching the acoustic characteristic impedance of the human tissues during use for endoscopic ultrasound examination. Disclosed herein is also a kit for endoscopic ultrasound examination, comprising the said biocompatible ultrasonic coupling agent.

Abstract: A method for defect inspection of a transparent substrate comprises (a) providing an optical system for performing a diffraction process of object wave passing through a transparent substrate, (b) interfering and wavefront recording for the diffracted object wave and a reference wave to reconstruct the defect complex images (including amplitude and phase) of the transparent substrate, (c) characteristics analyzing, features classifying and sieving for the defect complex images of the transparent substrate, and (d) creating defect complex images database based-on the defect complex images for comparison and detection of the defect complex images of the transparent substrate.

Abstract: The present specification describes a biocompatible hemostatic composition and a biocompatible tissue sealant, which when used in combination provides a safe and effective method of achieving hemostasis. The biocompatible composition and sealant may be applied either on a surface of the patient's body, or inside the body cavity. The combination may be used to control bleeding from external wounds and internal injuries, as well as to minimize bleeding during surgical procedures.

Abstract: The present disclosure relates to an retroreflective structural colour film and a preparation method thereof. The main steps are as follows: (1) assembling colloidal microspheres to form a monolayer of microspheres; and (2) transferring the monolayer of microspheres onto a transparent substrate which has an adhesive layer to make the monolayer of microspheres partially embedded in the adhesive layer to prepare the retroreflective structural colour film. The retroreflective material has the advantages of the simple preparation process, high reflective brightness and uniformity of reflection colour. Moreover, the retroreflective material can exhibit unique retroreflective structural colour under the illumination of a white light source.

Abstract: A composite containing hollow ceramic spheres and a preparation method are provided. The composite includes an impact-resistant gradient complex part containing a hollow ceramic sphere complex, prepared by using a 3D printing method and a hollow ceramic sphere-high polymer complex dielectric material obtained in a blending and fusing way. The obtained composite has the characteristics of relatively low density and high strength. The impact-resistant gradient complex part is a layered complex, the composition and properties of the complex may be regulated in a direction vertical to a layer according to a design, for example, mechanical properties of the complex are transitioned from soft to hard to form gradient change by regulating the change of the composition, and meanwhile, the thickness among layers with different properties is accurately controlled as required.

Abstract: A detection method including extracting features from an image, detecting a human in the image based on the extracted features, detecting an object in a surrounding region of the detected human based on the extracted features and determining human-object interaction information in the image based on the extracted features, the detected human and the detected object. The detection speed and detection precision of detecting the human, object and human-object interaction relationship from the video/image can be enhanced, and therefore the timeliness and accuracy of offering help to the human in need of help can be better met.

Abstract: A method of structured illumination digital holography includes: (a) providing a structured illumination generating unit and binarization random number encoding unit to generate a coded structured illumination pattern; (b) sampling at least two patterns with phase shift which synthesized as a single structured illumination pattern to be encoded; (c) forming a single digital hologram, and wavefront reconstructing the single digital hologram; (d) performing a compressive sensing approach to recover the object wave with at least two phase shift patterns; and (e) reconstructing the separation of overlap spectrum, to obtain an image covering bandpass spectrum with different high frequency and low frequency.

Abstract: Described herein is a composition for submucosal injection comprises a biocompatible modified starch and a pharmaceutically acceptable carrier for injection. The biocompatible modified starch is in an amount ranging from 0.2 wt % to 50 wt % of the total weight of composition. The biocompatible modified starch is selected from one or more of the group consisting of: etherified starches, esterified starches, cross-linked starches, pre-gelatinized starches, graft starches and composite modified starches, which has a molecular weight ranging from 3,000 to 2,000,000 daltons, a water absorbency capability of at least twice of its own weight, and a particle size from 500 nm to 1000 ?m. The viscosity of the composition ranges from 9 mPa·s to 150,000 mPa·s at 25° C. The present disclosure also provides a combination reagent for submucosal injection, comprising the above-mentioned biocompatible modified starch and the pharmaceutically acceptable carrier for injection.

Abstract: Provided herein are a biocompatible hemostatic product and a tissue sealant, including polyethylene oxide particles with a viscosity-average molecular weight ranging from 100,000 to 7,000,000 Daltons, a particle size ranging from 0.5 ?m to 2000 ?m and a water absorbency capacity ranging from 1 to 500 times of its own weight. Also provided herein is a method for preparing biocompatible hemostatic product and tissue sealant and the use of the biocompatible hemostatic product and tissue sealant in hemostasis, preventing adhesion, avoiding infection, promoting tissue healing, and sealing wound of tissues and organs either on animal's body surface, or inside body's cavity.

Abstract: Embodiments of the present application relate to a system for implementing screen capture, a method for implementing screen capture, and a computer program product for implementing screen capture. A method for implementing screen capture is provided.

Abstract: The present disclosure relates to an retroreflective structural colour film and a preparation method thereof. The main steps are as follows: (1) assembling colloidal microspheres to form a monolayer of microspheres; and (2) transferring the monolayer of microspheres onto a transparent substrate which has an adhesive layer to make the monolayer of microspheres partially embedded in the adhesive layer to prepare the retroreflective structural colour film. The retroreflective material has the advantages of the simple preparation process, high reflective brightness and uniformity of reflection colour. Moreover, the retroreflective material can exhibit unique retroreflective structural colour under the illumination of a white light source.

Abstract: A method of structured illumination digital holography includes: (a) providing a structured illumination generating unit and binarization random number encoding unit to generate a coded structured illumination pattern; (b) sampling at least two patterns with phase shift which synthesized as a single structured illumination pattern to be encoded; (c) forming a single digital hologram, and wavefront reconstructing the single digital hologram; (d) performing a compressive sensing approach to recover the object wave with at least two phase shift patterns; and (e) reconstructing the separation of overlap spectrum, to obtain an image covering bandpass spectrum with different high frequency and low frequency.

Abstract: A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

Abstract: A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

Abstract: An image processing method for processing a plurality of holograms includes the steps of: performing a Fourier transform operation on the holograms to result in a plurality of corresponding spectra in a spectrum space; calculating a sum of the plurality of spectra to obtain the synthetic spectrum; multiplying the synthetic spectrum by a weight function associated with the spectrum space to obtain a normalized synthetic spectrum, each function value of the weight function corresponding to a respective position in the spectrum space and being associated with distribution of the plurality of spectra in the spectrum space; and performing the inverse Fourier transform operation on the normalized synthetic spectrum to result in a normalized synthetic hologram.

Abstract: A method for defect inspection of a transparent substrate comprises (a) providing an optical system for performing a diffraction process of object wave passing through a transparent substrate, (b) interfering and wavefront recording for the diffracted object wave and a reference wave to reconstruct the defect complex images (including amplitude and phase) of the transparent substrate, (c) characteristics analyzing, features classifying and sieving for the defect complex images of the transparent substrate, and (d) creating defect complex images database based-on the defect complex images for comparison and detection of the defect complex images of the transparent substrate.

Abstract: Embodiments of the present application relate to a system for implementing screen capture, a method for implementing screen capture, and a computer program product for implementing screen capture. A method for implementing screen capture is provided.